참고문헌
- Adler DA (2010). The impact of HAART on HPV-related cervical disease. Curr HIV Res, 8, 493-7. https://doi.org/10.2174/157016210793499240
- Andrade ACVd, Luz PM, Velasque L, et al (2011). Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, Brazil. PloS one, 6, 18297. https://doi.org/10.1371/journal.pone.0018297
- Araujo ACL, Carvalho NO, Teixeira NC, et al (2012). Incidence of cervical intraepithelial neoplasia in a cohort of HIVinfected women. Int J Gynecol Obstet, 117, 211-6. https://doi.org/10.1016/j.ijgo.2011.12.024
- Beachler DC, Abraham AG, Silverberg MJ, et al (2014). Incidence and risk factors of HPV-related and HPV-unrelated head and neck squamous cell carcinoma in HIV-infected individuals. Oral Oncol, 50, 1169-76. https://doi.org/10.1016/j.oraloncology.2014.09.011
- Blossom DB, Beigi RH, Farrell JJ, et al (2007). Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol, 79, 758-65. https://doi.org/10.1002/jmv.20817
- Boletim Epidemiologico - Aids e DST (2014). Ministerio da saude - secretaria de vigilancia em saude - departamento de DST, aids e hepatites virais. Brasilia: Brasil.
- Brandao VCRAB, Lacerda RL, Ximenes RAA, et al (2010). Frequencia de Papilomavirus humano (HPV) e Chlamydia trachomatis em gestantes. Epidemiol Serv Saude, 19, 43-50.
- Correa CM, Teixeira NCP, Araujo ACLd, et al (2011). Prevalence and multiplicity of HPV in HIV women in Minas Gerais, Brazil. Rev Assoc Med Bras, 57, 425-30. https://doi.org/10.1590/S0104-42302011000400017
- De Sanjose S, Quint WGV, Alemany L, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11, 1048-56. https://doi.org/10.1016/S1470-2045(10)70230-8
- Denny LA, Franceschi S, de Sanjose S, et al (2012). Human Papillomavirus, Human Immunodeficiency Virus and Immunosuppression. Vaccine, 5, 168-74.
- Entiauspe LG, Teixeira LO, Mendoza-Sassi RA, et al (2010). Papilomavirus humano: prevalencia e genotipos encontrados em mulheres HIV positivas e negativas, em um centro de referencia no extremo Sul do Brasil. Rev Soc Bras Med Trop, 43, 260-3. https://doi.org/10.1590/S0037-86822010000300009
- Fedrizzi EN, Laureano JK, Schlup C, et al (2011). Infeccao pelo papilomavirus humano (HPV) em mulheres HIV-positivo de Florianopolis, Santa Catarina. DST J Bras Doencas Sex Transm, 23.
- Felix G, Ceolim MF (2012). O perfil da mulher portadora de HIV/AIDS e sua adesao a terapeutica antirretroviral. Rev Esc Enferm USP, 46, 884-91. https://doi.org/10.1590/S0080-62342012000400015
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Firnhaber C, Evans D, Friedman-Khalili R, et al (2011). Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana. J Clin Virol, 52, 265-8. https://doi.org/10.1016/j.jcv.2011.08.011
- Instituto Nacional de Cancer - INCA (2014). Incidencia de Cancer no Brasil, estimativa 2014. Rio de Janeiro, RJ, Brasil.
- Instituto Nacional de Cancer - INCA (2014). Estimativas: Neoplasia maligna do colo do utero.
- International Agency for Research on Cancer (IARC) - World Health Organization (2012). Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012.
- International Agency for Research on Cancer (IARC) - World Health Organization (2011). Monographs on the evaluation of carcinogenic risk to humans. Volume 100B: A review of human carcinogens: biological agents. Lyon - France.
- Jalil EM, Bastos FI, Melli PP, et al (2013). HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. BMC Infectious Diseases, 13, 564. https://doi.org/10.1186/1471-2334-13-564
- Joura EA, Giuliano AR, Iversen OE, et al (2015). A 9-Valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med, 372, 711-23. https://doi.org/10.1056/NEJMoa1405044
- Koh WJ, Greer BE, Abu-Rustum NR, et al (2015). Cervical cancer, version 2.2015. JNCCN, 13, 395-404.
- Kurman RJ, Ellenson LH, Ronnett BM (2011). Blaustein's Pathology of the female genital tract, 6th edn. New York: Springer Verlag, 1246.
- Lima MDM, Braz-Silva PH, Pereira SM, et al (2014). Oral and cervical HPV infection in HIV-positive and HIV-negative women attending a sexual health clinic in Sao Paulo, Brazil. Int J Gynecol Obstet, 126, 33-6. https://doi.org/10.1016/j.ijgo.2014.01.017
- Luque AE, Hitti J, Mwachari C, et al (2010). Prevalence of human Papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). J Infect Dis, 14, 810-804.
- Marur S, D'Souza G, Westra W, et al (2010). HPV-associated head and neck cancer: a virus related cancer epidemic. Lancet Oncol, 11, 781-9. https://doi.org/10.1016/S1470-2045(10)70017-6
- Mattos ATd, Freitas LBd, Lima BMC, et al (2011). Diversity and uncommon HPV types in HIV seropositive and seronegative women attending an STI clinic. Braz J Microbiol, 42, 786-93. https://doi.org/10.1590/S1517-83822011000200047
- McKenzie ND, Kobetz EN, Hnatysyn J, et al (2010). Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol, 116, 572-7. https://doi.org/10.1016/j.ygyno.2009.10.058
- Melgaco FG, Rosa MLG, Augusto EF, et al (2011). Human papillomavirus genotypes distribution in cervical samples from women living with human immunodeficiency virus. Arch Gynecol Obstet, 283, 809-17. https://doi.org/10.1007/s00404-010-1443-z
- Meyrelles ARI, Siqueira JD, Hofer CB, et al (2013). HIV/ HPV co-infection during pregnancy in southeastern Brazil: Prevalence, HPV types, cytological abnormalities and risk factors. Gynecol Oncol, 128, 107-12. https://doi.org/10.1016/j.ygyno.2012.10.003
- Oliveira PM, Oliveira RPC, Travessa IEM, et al (2010). Prevalence and risk factors for cervical intraepithelial neoplasia in HIV-infected women in Salvador, Bahia, Brazil. Sao Paulo Med J, 128, 197-201. https://doi.org/10.1590/S1516-31802010000400004
- Ortiz AP, Perez-Irizarry J, Soto-Salgado M, et al (2014). Human papillomavirus-related cancers among people living with AIDS in Puerto Rico. Prev Chronic Dis, 11, 80.
- Paim J, Travassos C, Almeida C, et al (2011). The Brazilian health system: history, advances, and challenges. Lancet, 377, 1778-97. https://doi.org/10.1016/S0140-6736(11)60054-8
- Paulo M, Borges AB, Duarte G, et al (2007). The environmental cofactors in carcinogenesis in high risk HPV/HIV-positive women. Braz J Infect Dis, 11, 189-95. https://doi.org/10.1590/S1413-86702007000200003
- Piketty C, Selinger-Leneman H, Bouvier A-M, et al (2012). Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. Clin Oncol, 30, 4360-6. https://doi.org/10.1200/JCO.2012.44.5486
- Portal Brasil (2015). Mortalidade de AIDS cai 13% nos ultimos 10 anos no Brasil.
- Portal Brasil (2015). Relatorio contabiliza casos de HIV/AIDS na America Latina.
- Requejo HIZ (2006). Worldwide molecular epidemiology of HIV. Rev Saude Publica, 40, 331-45. https://doi.org/10.1590/S0034-89102006000200023
- Rocha-Brischiliari SC, Gimenes F, de Abreu ALP, et al (2014). Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women. Infec Agents Cancer, 9, 1-6. https://doi.org/10.1186/1750-9378-9-1
- Rosa MI, Fachel JM, Rosa DD, et al (2008). Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol, 199, 617.
- Santos NJS, Barbosa RM, Pinho AA, et al (2009). Contextos de vulnerabilidade para o HIV entre mulheres brasileiras. Cad Saude Publica, 25, 321-33. https://doi.org/10.1590/S0102-311X2009000200010
- Shrestha S, Sudenga SL, Smith JS, et al (2010). The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infect Dis, 10, 295. https://doi.org/10.1186/1471-2334-10-295
- Smith-McCune KK, Shiboski S, Chirenje MZ, et al (2010). Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PloS one, 5, 10094. https://doi.org/10.1371/journal.pone.0010094
- Solomon D, Nayar R (2005). Sistema Bethesda para citopatologia cervicovaginal: definicoes, criterios e notas explicativas: Revinter.
- Spangler JM, Munger K (2010). The human Papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol, 84, 9398-407. https://doi.org/10.1128/JVI.00974-10
- Stier E (2009). Human papillomavirus related diseases in HIVinfected individuals. Curr Opin Oncol, 20, 541-6.
- Sudenga SL, Wiener HW, King CC, et al (2014). Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS). Plos One, 9, 99109. https://doi.org/10.1371/journal.pone.0099109
- Teixeira NCP, Araujo ACL, Correa CM, et al (2012). Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women. Braz J Infect Dis, 16, 164-9. https://doi.org/10.1016/S1413-8670(12)70299-4
- Tornatore M, Goncalves CV, Bianchi MS, et al (2012). Coinfections associated with human immunodeficiency virus type 1 in pregnant women from southern brazil: high rate of intraepithelial cervical lesions. Mem Inst Oswaldo Cruz, 107, 205-10. https://doi.org/10.1590/S0074-02762012000200009
- Vaz LP, Saddi VA, Amaral WNd, et al (2011). Epidemiologia da infeccao pelo HPV em mulheres infectadas pelo HIV. Femina, 39, 35-40.
피인용 문헌
- Sociodemographic determinants of abnormal cervical cytology among HIV positive women in Nnewi, Nigeria vol.9, pp.10, 2017, https://doi.org/10.5897/IJMMS2017.1322